or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell lymphoma depends on the subtype — of which there are ...

Chronic lymphocytic leukemia (CLL) is a slow-growing cancer that affects white blood cells. Survival rates tend to ... Experts don’t exactly know what causes CLL. However, there are risk factors ...

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left without hope.” ...

Jan. 16, 2025 — Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials ... New Innovative Local ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...

Using human T cells and leukemia cells in specialized mouse models ... offering a groundbreaking innovation that could eventually improve survival and quality of life for patients with some ...

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...

Older patients and those with genetic risk factors were at particularly high risk of relapse and had poorer overall survival.